Solventum Corporation/$SOLV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Solventum Corporation
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
Ticker
$SOLV
Sector
Primary listing
NYSE
Employees
20,584
Headquarters
Website
SOLV Metrics
BasicAdvanced
$12B
7.73
$8.88
-
-
Price and volume
Market cap
$12B
52-week high
$88.20
52-week low
$60.70
Average daily volume
1.2M
Financial strength
Current ratio
1.231
Quick ratio
0.658
Long term debt to equity
102.555
Total debt to equity
99.723
Interest coverage (TTM)
2.25%
Profitability
EBITDA (TTM)
1,166
Gross margin (TTM)
53.57%
Net profit margin (TTM)
18.69%
Operating margin (TTM)
9.37%
Effective tax rate (TTM)
9.17%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
2.94%
Return on equity (TTM)
38.86%
Valuation
Price to earnings (TTM)
7.725
Price to revenue (TTM)
1.435
Price to book
2.36
Price to tangible book (TTM)
-3.67
Price to free cash flow (TTM)
-1,194.331
Free cash flow yield (TTM)
-0.08%
Free cash flow per share (TTM)
-0.057
Growth
Revenue change (TTM)
0.86%
Earnings per share change (TTM)
221.74%
3-year revenue growth (CAGR)
0.79%
3-year earnings per share growth (CAGR)
4.52%
What the Analysts think about SOLV
Analyst ratings (Buy, Hold, Sell) for Solventum Corporation stock.
SOLV Financial Performance
Revenues and expenses
SOLV Earnings Performance
Company profitability
SOLV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Solventum Corporation stock?
Solventum Corporation (SOLV) has a market cap of $12B as of March 10, 2026.
What is the P/E ratio for Solventum Corporation stock?
The price to earnings (P/E) ratio for Solventum Corporation (SOLV) stock is 7.73 as of March 10, 2026.
Does Solventum Corporation stock pay dividends?
No, Solventum Corporation (SOLV) stock does not pay dividends to its shareholders as of March 10, 2026.
When is the next Solventum Corporation dividend payment date?
Solventum Corporation (SOLV) stock does not pay dividends to its shareholders.
What is the beta indicator for Solventum Corporation?
Solventum Corporation (SOLV) does not currently have a Beta indicator.